Narcolepsy
📧 Sign up to get email alerts when something new happens for Narcolepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved a supplemental application for Methylphenidate Hydrochloride by Lupin Pharmaceuticals, Inc., updating an aspect of the prod…
-
FDA approval · 2017-01-04FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) submitted by Amneal Pharmaceuticals LLC.
-
FDA approval · 2017-01-04FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate hydrochloride products from Sandoz Inc.
-
FDA approval · 2017-01-04FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for RITALIN (methylphenidate hydrochloride) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate (SpecGx LLC), resulting in approval for a generic version of the drug.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application by Wilshire Pharmaceuticals, Inc. for dextroamphetamine sulfate, enabling a generic version of t…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Aurolife Pharma, LLC)
FDA approves a supplemental application for a generic form of dextroamphetamine sulfate by Aurolife Pharma, enabling its market authorizatio…
-
FDA approval · 2017-01-04FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EVEKEO, a brand-name amphetamine sulfate product from Azurity Pharmaceuticals, under ANDA 200166…
-
FDA approval · 2017-01-04FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for a generic fixed-dose combination of four amphetamine salts (dextroamphetamine saccharate, amphet…
-
FDA approval · 2016-12-27FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for a generic dextroamphetamine sulfate product.
-
FDA approval · 2016-11-28FDA Approved: ARMODAFINIL — Original Application (Natco Pharma USA LLC)
The FDA approved Natco Pharma USA LLC's original application for armodafinil, enabling generic armodafinil to enter the market.
-
FDA approval · 2016-11-07FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for methylphenidate hydrochloride from Rising Pharma Holdings, Inc., a generic stimulant indicated for…
-
FDA approval · 2016-10-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a methylphenidate hydrochloride generic product manufactured by SpecGx LLC.
-
FDA approval · 2016-10-28FDA Approved: DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for a generic product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetam…
-
FDA approval · 2016-10-28FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for dextroamphetamine sulfate by SpecGx LLC under an ANDA. This action confirms the approval of a ge…
-
FDA approval · 2016-10-25FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application from SpecGx LLC for dextroamphetamine sulfate extended-release, clearing a generic extended-rele…
-
FDA approval · 2016-09-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for four amphetamine salt products (dextroamphetamine saccharate, amphetamine aspartate, dextro…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
A completed observational study evaluating risks of side effects, drug abuse, and dependence in patients prescribed Xyrem (sodium oxybate) f…
-
FDA approval · 2016-07-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's generic methylphenidate hydrochloride product under an Original Application. It is…
-
FDA approval · 2016-06-23FDA Approved: SODIUM OXYBATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for sodium oxybate filed by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2016-06-15FDA Approved: MODAFINIL — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Modafinil from Alembic Pharmaceuticals Limited. The approval confirms the ability to market the …
-
FDA approval · 2016-03-16FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin's dextroamphetamine sulfate as an original ANDA, enabling a generic version of the stimulant for ADHD and narcolepsy.
-
FDA approval · 2016-02-16FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved an original application for a generic mixed amphetamine salts product (dextroamphetamine and amphetamine salts) from Amneal Pha…
-
FDA approval · 2016-02-09FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for methylphenidate from Sandoz Inc, resulting in an expanded/updated authorization for the product.
-
FDA approval · 2016-01-28FDA Approved: MODAFINIL — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for modafinil filed by Bionpharma Inc. to market a generic wakefulness-promoting drug.